Cargando…
Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization
Antibodies targeting IL-17A or its receptor IL-17RA show unprecedented efficacy in the treatment of autoimmune diseases such as psoriasis. These therapies, by neutralizing critical mediators of immunity, may increase susceptibility to infections. Here, we compared the effect of antibodies neutralizi...
Autores principales: | Segueni, Noria, Tritto, Elaine, Bourigault, Marie-Laure, Rose, Stéphanie, Erard, François, Le Bert, Marc, Jacobs, Muazzam, Di Padova, Franco, Stiehl, Daniel P., Moulin, Pierre, Brees, Dominique, Chibout, Salah-Dine, Ryffel, Bernhard, Kammüller, Michael, Quesniaux, Valerie F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113257/ https://www.ncbi.nlm.nih.gov/pubmed/27853279 http://dx.doi.org/10.1038/srep36923 |
Ejemplares similares
-
Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG
por: Bourigault, Marie-Laure, et al.
Publicado: (2013) -
Innate type 1 immune response, but not IL-17 cells control tuberculosis infection
por: Segueni, Noria, et al.
Publicado: (2021) -
Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection
por: Segueni, Noria, et al.
Publicado: (2015) -
Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections
por: Kammüller, Michael, et al.
Publicado: (2017) -
TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis
por: Arbués, Ainhoa, et al.
Publicado: (2020)